What is VitaDAO?

VitaDAO is a unique DAO dedicated to revolutionizing the future of longevity. Through its vibrant community of scientists, entrepreneurs, and enthusiasts, VitaDAO funds and directs cutting-edge anti-aging research. By driving decisions and governance, it empowers members to shape breakthroughs that could redefine human healthspan and extend our lifetimes.This community-driven model represents a significant shift in funding and guiding early-stage biotech research, allowing participants to directly influence the future of longevity science.

Problem

VitaDAO had previously faced engagement challenges, due to reliance on traditional Web 2.0 tools.

Despite having a clear mission, a dedicated team, and the introduction of the VITA token, VitaDAO struggled to manage multiple initiatives simultaneously. This complexity led to confusion and disengagement among members.

To overcome these limitations, VitaDAO recognized the need to tap into what makes Web3 communities unique. They saw an opportunity in Common's Web3-native platform, specifically its gating features, wallet login, and bidirectional Snapshot integration, to drive engagement and effectively manage subDAOs.

Solution

SubDAOs are smaller, specialized entities within a larger DAO, focusing on specific projects or areas while maintaining alignment with the main DAO's goals. They operate with their own governance structures, and encourage independent decision-making on niche matters, while coordinating with the central DAO for larger initiatives.

VitaDAO implemented SubDAOs to streamline their grand mission by using Common to allocate two $200,000 grants for the creation of new on-chain assets: VitaRNA and VitaFAST. This approach allowed VitaDAO to manage distinct projects more effectively.

Let's dive into each of these SubDAOs and their success.

1. VitaRNA:

VitaRNA is a gene therapy project initiated by VitaDAO in partnership with Artan Bio, aiming to fundraise to advance research that could address aging-related genetic factors.

VitaRNA tokens give the VitaDAO community governance rights over the project's IP and R&D efforts, allowing members to vote on key decisions like research priorities and fund allocation.

The excitement around VitaRNA stems from its potential to decentralize and democratize medical innovation, creating a transparent and inclusive path towards breakthrough therapies that could enhance human healthspan and longevity.Common enabled more nuanced and impactful governance, as voting rights were tied to members' commitment and contributions.

VitaRNA on Common

VitaRNA has introduced two key proposals using Common.

• VRNAP-1, aims to establish a governance framework by creating two working groups: the Web3 Pod and the Biotech Pod. This structure is designed to enhance both community involvement and scientific progress.
  
• ‍VRNAP-2, suggests allocating $100,000 worth of ETH from the VitaRNA treasury to fund experiments as detailed in the VitaRNA Whitepaper. To refine and test promising drug candidates in the VITA-FAST project

These initiatives are part of a broader strategy to drive innovation and strengthen community participation.

2. VitaFAST:

VitaFast engages VitaDAO members by giving them a hands-on role in directing the future of longevity research. As VITA-FAST tokenholders, members are not just passive contributors; they actively participate in governance, resource allocation, research priorities, and more.

This decentralized approach empowers a diverse community to collaboratively shape groundbreaking advancements in anti-aging therapies. Every participant has the opportunity to influence the trajectory of cutting-edge discoveries, a thrilling prospect for the future of longevity and human healthspan.

VitaFAST on Common
‍
VitaDAO engaged their community and approved a $45,000 budget for the next phase of the VITA-FAST project. This funding will support expert consulting and purchase of new chemical compounds, crucial for drug optimization and development.

• Total Budget Approved: $45,000 for Expert Consulting & Custom and Commercial Compounds
• Purpose: To refine and test promising drug candidates in the VITA-FAST project
• Phase: Transition from initial screenings to detailed drug optimization
• Impact: Crucial for advancing the project and discovering new treatments for aging

Results

This implementation of SubDAOs highlights how VitaDAO leverages Common to:

• Streamline Project Management: SubDAOs focus on specific initiatives, enhancing efficiency and clarity
• Boost Community Engagement: Members actively participate in governance, influencing key decisions and funding allocations
• Utilize Common’s Superpowers: Common enables communities to propose, discuss, and implement solutions directly within the platform

This approach not only supports VitaDAO's mission to advance longevity research but also sets a precedent for how decentralized communities can drive innovation and impact with SubDAOs and specialized communities on Common.